About ProteinQure Inc
dare to deliver
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Toronto, Ontario
- Founded
- 2017
- Company type
- Privately Held
- Company profile name
- ProteinQure
ProteinQure is building the world’s leading AI platform for peptide drug design, focused on extracellular targets. Our lead program, PQ203 for TOP1-resistant triple-negative breast cancer - a disease with no approved treatment options - has just entered Phase I trials in the US and Canada.
Our platform has been validated in collaborations with four of the top 25 pharmaceutical companies and leverages proprietary physics-based methods to explore the largest accessible chemical space, spanning full scaffold diversity and more than 3,500 non-canonical building blocks.
Beyond partnerships, we are advancing internal programs that use novel peptides to enable tissue-specific payload delivery, including next-generation approaches for siRNA delivery to the CNS.
Company locations
108 College St, Toronto, Ontario M5G 0C6, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
Business areas
- Biotechnology
- Life Science
- Artificial Intelligence (AI)
- Pharmaceutical
On LinkedIn
- Followers
- 7,783
- People linked to this company
- 33
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
18,120,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.